MEDP - Company ID 0001668397
The table below shows Medpace Holdings, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $706.60M | $659.90M | $603.31M | $558.57M | $533.32M | $528.10M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Medpace Holdings, Inc. reported annual revenue of $2.53B for fiscal year 2025. That is up 20.0% from $2.11B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $421.58M (FY 2016) to $2.53B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $47.92M |
| $48.08M |
| $46.66M |
| $57.90M |
| $49.22M |
| $41.45M |
| Operating income | $141.50M | $141.81M | $126.33M | $113.52M | $112.27M | $105.15M |
| Income tax | $23.72M | $31.70M | $34.28M | $3.58M | $22.35M | $22.13M |
| Net income | $123.87M | $111.14M | $90.26M | $114.59M | $96.43M | $88.35M |
| EPS (diluted) | $4.28 | $3.86 | $3.10 | $3.67 | $3.01 | $2.75 |